ClinicalTrials.Veeva

Menu

Cohort Study for Atrial Fibrillation Risk Stratification (AFHRI)

U

Universitätsklinikum Hamburg-Eppendorf

Status

Enrolling

Conditions

Atrial Fibrillation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.

Full description

The primary aim of the study is to evaluate and improve atrial fibrillation risk prediction, which takes into account clinical, psycho-social, environmental and lifestyle-risk factors, protein patterns and genetic variability in addition to the classical risk factors with respect to the primary endpoint, AF (paroxysmal or permanent).

Enrollment

3,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 to 85 years;
  • Personally signed informed consent

Exclusion criteria

  • Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation;
  • Physical or psychological incapability to cooperate in the investigations

Trial contacts and locations

1

Loading...

Central trial contact

Renate B Schnabel, Prof.; Daniel Engler, MSc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems